Our Philosophy


Janssen Therapeutics' vision is to provide innovative virology therapeutics that help healthcare professionals address serious unmet needs in people living with HIV and/or Hepatitis C. As a division of Janssen Products, LP, Janssen Therapeutics is a leading biotechnology company and part of the
Johnson & Johnson Family of Companies, the world's most comprehensive and broadly based manufacturer of health care products.

Janssen Therapeutics strives to be a leader in the field of virology by supporting relevant, innovative, and quality education that enhances understanding of virology therapeutics and improves the lives of people with HIV and/or Hepatitis C. We are committed to supporting educational programs for patients and healthcare professionals that are aligned with our vision and our areas of interest.

All grant requests are reviewed for compliance with our policies and relevant legal and industry requirements, including the guidelines set forth by the Food and Drug Administration (FDA), the Pharmaceutical Research and Manufacturers of America (PhRMA), and the Accreditation Council for Continuing Medical Education (ACCME).